GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (LTS:0GQU) » Definitions » Research & Development

Active Biotech AB (LTS:0GQU) Research & Development : kr31.64 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Active Biotech AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Active Biotech AB's Research & Development for the three months ended in Mar. 2024 was kr7.10 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr31.64 Mil.

Active Biotech AB Research & Development Historical Data

The historical data trend for Active Biotech AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Research & Development Chart

Active Biotech AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.47 25.55 34.54 42.82 32.54

Active Biotech AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.10 7.30 7.60 9.64 7.10

Active Biotech AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr31.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB  (LTS:0GQU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Active Biotech AB Research & Development Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Active Biotech AB (LTS:0GQU) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (LTS:0GQU) » Definitions » Research & Development
Comparable Companies
OSTO:SANION OSTO:BIOVIC B OSTO:GUARD OSTO:ACOU OSTO:XINT OSTO:NICA OSTO:ABLI OSTO:CLBIO XSAT:CESSA OSTO:INDEX OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
ACTI:Sweden BTPC:Germany
Address
Scheelevagen 22, Lund, SWE, 223 63
Website
https://www.activebiotech.com
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (LTS:0GQU) Headlines

No Headlines